These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23842634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus.
    Woo VC.
    Clin Ther; 2017 Aug; 39(8S2):S12-S33. PubMed ID: 28187863
    [Abstract] [Full Text] [Related]

  • 7. Insulin degludec (Tresiba)--a new long-acting insulin for diabetes.
    Med Lett Drugs Ther; 2015 Dec 07; 57(1483):163-4. PubMed ID: 26633683
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 11. [Early insulin therapy in type 2 diabetes?].
    Birkeland KI.
    Tidsskr Nor Laegeforen; 2012 Oct 16; 132(19):2151-2. PubMed ID: 23076480
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
    Rausch R.
    Med Monatsschr Pharm; 2014 Jul 16; 37(7):273-4. PubMed ID: 25065174
    [No Abstract] [Full Text] [Related]

  • 14. Degludec: a novel basal insulin.
    Kalra S, Baruah MP, Niazi AK.
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Jan 16; 6(1):18-23. PubMed ID: 22280221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide.
    Vedtofte L, Knop FK, Vilsbøll T.
    Expert Rev Clin Pharmacol; 2015 May 16; 8(3):273-82. PubMed ID: 25816888
    [Abstract] [Full Text] [Related]

  • 17. Insulin degludec/liraglutide (Xultophy 100/3.6) for type 2 diabetes.
    Med Lett Drugs Ther; 2017 Sep 11; 59(1529):147-149. PubMed ID: 28880845
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.